Husain-Syed, Faeq
Emlet, David R.
Wilhelm, Jochen
Danesi, Tommaso Hinna
Ferrari, Fiorenza
Bezerra, Pércia
Lopez-Giacoman, Salvador
Villa, Gianluca
Tello, Khodr
Birk, Horst-Walter
Seeger, Werner
Giavarina, Davide
Salvador, Loris
Fuhrman, Dana Y.
Kellum, John A.
Ronco, Claudio
Caprara, Carlotta
Corradi, Valentina
Cal, Massimo
Estremadoyro, Carla
Lu, Renhua
Samoni, Sara
Sharma, Aashish
Tofani, Lorenzo
Virzì, Grazia Maria
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effects of preoperative high-oral protein loading on short- and long-term renal outcomes following cardiac surgery: a cohort study
https://doi.org/10.1186/s12967-022-03410-x
Funding for this research was provided by:
Justus-Liebig-Universität Gießen
Article History
Received: 13 September 2021
Accepted: 24 April 2022
First Online: 10 May 2022
Declarations
:
: Approval by the local ethics committee (Comitato Etico per le Sperimentazioni Cliniche della Provincia di Vicenza) was granted before initiating enrollment (79/16F). Written informed consent was obtained from the patients by a member of the research team.
: Not applicable.
: KT has received speaking fees from Actelion and Bayer outside the submitted work. WS has received speaker/consultancy fees from Pfizer and Bayer Pharma AG outside the submitted work. JAK discloses inventorship on a patent application held by the Universities of Pittsburgh, and Munster, and Astute Medical (US2018/074054A1) for use of TIMP-2 and IGFBP7 in conjunction with interventions to protect the kidney. CR reports support for acting as an advisory board member for ASAHI, Baxter, GE, Jafron, and Medtronic, and speaker’s fees from Astute, bioMérieux, B. Braun, Cytosorbents, ESTOR, FMC, and Toray, all unrelated to the submitted work. All other authors have declared that no conflict of interests exists.